Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

ERISA Recap: 4 Rulings Worth Paying Attention To From Nov. No Photo Available

Kellie Mejdrich

The Ninth Circuit striking down a class action win for transgender employee health plan participants who said their gender-affirming c... (more story)

CDC Panel Ends Recommendation Of Hepatitis B Shot At Birth No Photo Available

Yeji Jesse Lee

A panel of federal vaccine advisers on Friday voted to lift a long-standing recommendation that all newborns be given vaccinations for hepatitis B.

Lawyers Adapt To Crop Of New FDA Pilots No Photo Available

Yeji Jesse Lee

A slew of new FDA pilot programs is forcing life science attorneys to adjust to a new reality of programs that shed bureaucratic proce... (more story)